Concord Healthcare rises after China approves therapy services licence

Concord Healthcare

16/09/2024 03:13

** Shares of Hong Kong-listed Concord Healthcare Group
 2453.HK  rise as much as 5.7% to HK$18.56, their biggest
intraday pct gain since Aug 1
    ** Stock of the oncology healthcare service provider on
track to snap six consecutive sessions of decline, and is fifth
pct gainer in healthcare index  .HSCIH , which is down 1.2%
    ** Concord Healthcare said China's National Health
Commission had on Sept 13 granted approval to the company's
application for licence to deploy large-scale medical equipment
for its planned proton therapy services 
    ** Hang Seng Commerce & Industry Index  .HSNC  slips 0.5%
and Hang Seng Index  .HSI  eases 0.4%
    


 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))